Literature DB >> 22622495

The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care.

Luca De Nicola1, Roberto Minutolo, Paolo Chiodini, Silvio Borrelli, Carmine Zoccali, Maurizio Postorino, Carmela Iodice, Felice Nappi, Giorgio Fuiano, Ciro Gallo, Giuseppe Conte.   

Abstract

To define whether age modifies the prognosis of patients with chronic kidney disease (CKD) on nephrology care, we prospectively followed patients with CKD who have been receiving nephrology care in a clinic for 1 year or more. The incidence of end-stage renal disease (ESRD), defined by the occurrence of dialysis or transplant, or death without ESRD was estimated by a competing-risk approach, and interactions between age and risk factors tested in Cox models over a median follow-up period of 62.4 months. Of 1248 patients with stage III–V CKD, 481 were younger than 65, 410 were between 65 and 75, and 357 were over 75 years old. Within each age class, the mean estimated glomerular filtration rate(eGFR) was 31, 32, and 29 ml/min per 1.73 m2, respectively. There were 394 ESRD events and 353 deaths. The risk of ESRD was higher than the risk of death without ESRD for ages <60 years, and independent of eGFR. The ESRD risk diminished with aging but still prevailed for eGFRs of 25–35 in patients between 65 and 75 years and with an eGFR below 15 in those up to 85 years old. Proteinuria significantly increased the risk of ESRD with advancing age. Surprisingly, the unfavorable effects of cardiovascular disease on ESRD and of diabetes on survival significantly decreased with increasing age. Male gender, higher phosphate, lower body mass index, and hemoglobin were age-independent predictors for ESRD, while cardiovascular disease, lower hemoglobin, higher proteinuria and uric acid, and ESRD also predicted death. Thus, in older patients on nephrology care, the risk of ESRD prevailed overmortality even when eGFR was not severely impaired. Proteinuria increases ESRD risk, while the predictive role of other modifiable risk factors was unchanged compared with younger patients.

Entities:  

Mesh:

Year:  2012        PMID: 22622495     DOI: 10.1038/ki.2012.174

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  32 in total

1.  Predicting Risk of RRT in Patients with CKD.

Authors:  Morgan E Grams; Josef Coresh
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-27       Impact factor: 8.237

2.  Responsiveness to erythropoiesis-stimulating agents in chronic kidney disease: does geography matter?

Authors:  Luca De Nicola; Francesco Locatelli; Giuseppe Conte; Roberto Minutolo
Journal:  Drugs       Date:  2014-02       Impact factor: 9.546

3.  Combined application of eGFR and albuminuria for the precise diagnosis of stage 2 and 3a CKD in the elderly.

Authors:  Conghui Liu; Haiping Chen; Cuiyun Liu; Chen Fu; Hui Zhang; Huayu Yang; Peng Wang; Fan Wang; Shujun Chen; Qing Ma
Journal:  J Nephrol       Date:  2014-03-08       Impact factor: 3.902

Review 4.  Atherosclerotic-nephropathy: an updated narrative review.

Authors:  Mariadelina Simeoni; Silvio Borrelli; Carlo Garofalo; Giorgio Fuiano; Ciro Esposito; Alessandro Comi; Michele Provenzano
Journal:  J Nephrol       Date:  2020-04-08       Impact factor: 3.902

Review 5.  Obesity Paradox in Advanced Kidney Disease: From Bedside to the Bench.

Authors:  Neda Naderi; Carola-Ellen Kleine; Christina Park; Jui-Ting Hsiung; Melissa Soohoo; Ekamol Tantisattamo; Elani Streja; Kamyar Kalantar-Zadeh; Hamid Moradi
Journal:  Prog Cardiovasc Dis       Date:  2018-07-04       Impact factor: 8.194

6.  Association of Body Mass Index with Clinical Outcomes in Non-Dialysis-Dependent Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Seyed-Foad Ahmadi; Golara Zahmatkesh; Emad Ahmadi; Elani Streja; Connie M Rhee; Daniel L Gillen; Luca De Nicola; Roberto Minutolo; Ana C Ricardo; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Cardiorenal Med       Date:  2015-10-16       Impact factor: 2.041

7.  Interaction between phosphorus and parathyroid hormone in non-dialysis CKD patients under nephrology care.

Authors:  Luca De Nicola; Giuseppe Conte; Paolo Chiodini; Pierluigi D'Angiò; Gerardo Donnarumma; Roberto Minutolo
Journal:  J Nephrol       Date:  2013-12-06       Impact factor: 3.902

Review 8.  Epidemiology and Public Health Concerns of CKD in Older Adults.

Authors:  Enrica Fung; Manjula Kurella Tamura
Journal:  Adv Chronic Kidney Dis       Date:  2016-01       Impact factor: 3.620

9.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  Infection       Date:  2018-09-25       Impact factor: 3.553

10.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  J Nephrol       Date:  2018-09-25       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.